Follow The Filings

MCB Metropolitan Bank

Metropolitan Bank earnings company data as of 4:46 AM ET 10/5

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MCB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MCB insider trades
  • $253K bought by 3 insiders
  • $4.1M sold by 3 insiders outside a trading plan
  • $389K sold by 1 insider under 10b5-1 plans
  1. Dale C Fredston Director
    Sale
    $178K 2,000 shares at $89.09 12% of stake
    Traded Sep 17 Filed Sep 18
  2. Robert C Patent Director
    Sale
    $923K 10,000 shares at $92.29 12% of stake
    Traded Aug 10 Filed Aug 12
  3. Daniel F Dougherty CFO
    Buy
    $90K 1,000 shares at $89.98 +3.1% to stake
    Traded Jul 23 Filed Jul 27
  4. Nick Rosenberg Executive Vice President
    Planned sale
    $190K 1,897 shares at $100.41 7.9% of stake
    Traded Jun 30–Jul 1 Filed Jul 2
  5. Nick Rosenberg Executive Vice President
    Planned sale
    $35K 353 shares at $100.02 1.4% of stake
    Traded Jun 26–29 Filed Jun 29
  6. Robert C Patent Director
    Sale
    $964K 10,000 shares at $96.41 10% of stake
    Traded Jun 12 Filed Jun 15
  7. Robert C Patent Director
    Sale
    $451K 5,000 shares at $90.21 4.9% of stake
    Traded Jun 4 Filed Jun 5
  8. Harvey Gutman Director
    Sale
    $269K 3,000 shares at $89.58 14% of stake
    Traded May 29 Filed Jun 1
  9. Daniel F Dougherty CFO
    Buy
    $80K 1,000 shares at $79.95 +3.2% to stake
    Traded Mar 10 Filed Mar 11
  10. Robert C Patent Director
    Sale
    $1.4M 14,445 shares at $94.16
    Traded Jan 22–23 Filed Jan 26
  11. Nick Rosenberg Executive Vice President
    Planned sale
    $113K 1,250 shares at $90.21 4.6% of stake
    Traded Jan 21 Filed Jan 22
  12. Nick Rosenberg Executive Vice President
    Planned sale
    $50K 625 shares at $80.41 2.3% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
  13. Anthony J Fabiano Director
    Buy
    $9,978 147 shares at $67.87 +1.2% to stake
    Traded Oct 30, 2025 Filed Nov 3, 2025
  14. Daniel F Dougherty CFO
    Buy
    $72K 1,000 shares at $71.66 +3.8% to stake
    Traded Oct 27, 2025 Filed Oct 28, 2025
  15. Frederik F Erikson EVP & General Counsel
    Buy
    $1,373 20 shares at $68.65 +0.3% to stake
    Traded Oct 27, 2025 Filed Oct 28, 2025

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 11 share withholdings for taxes, 1 sale back to the company, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 2.02,7.01,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 5.07
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
DEF 14A FORM DEF 14A
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.